Psoriasis Treatment Market for Acne and Psoriasis in North America and Europe: Hospitals Account for Leading Revenue Share


Published on : Dec 18, 2017

Albany, New York, December 18, 2017: A new research report highlighting the advances made in phototherapy treatment in North America and Europe has been added to the repository of Market Research Hub (MRH). The report titled “Phototherapy Treatment Market for Acne and Psoriasis: North America and Europe Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 – 2027” offers detailed insights and analysis on the key factors impacting the growth of the phototherapy treatment market for acne and psoriasis in North America and Europe.

According to the report, while topical gels/creams remain the first line of defense for psoriasis, there has been an increase in advanced treatment options for dealing with complex skin issues. Phototherapy, although still to be used widely in North America and Europe, is steadily gaining traction among end-users as more dermatologists are educating people about the benefits of this treatment option. On account of these factors, the phototherapy treatment market for acne and psoriasis in North America and Europe is likely to grow at a CAGR of nearly 6% during the assessment period.

According to the report, research and development efforts are more prominent in North America and Europe which has led to greater awareness about the benefits of phototherapy treatment among healthcare providers in these regions. These two regions are taking the lead in terms of developing new technology and equipment so that more effective treatment can be administered to the target audience.

The report projects hospitals to be the leading end-user segment that is likely to push up demand for phototherapy during the assessment period. For many people with skin problems, hospitals are the first point of contact for getting a prescription and treatment, and phototherapy options have been suggested as a novel method of managing complex cases. However, an increasing preference for homecare settings has been observed as more patients are comfortable getting this kind of treatment in their own homes. Among the different types of therapy treatment options available, a preference for blue light therapy has been observed. According to the report, there is a high likelihood that blue light phototherapy will continue to gain traction among end-users during the assessment period. By 2027, valuation of blue light therapy in the use of acne and psoriasis treatment in North America and Europe is likely to surpass US$ 1 Bn in revenues.

Some of the leading companies profiled in the report include   Lifespan, UC Irvine Health, National Skin Centre, Blackrock Clinic Limited, Buffalo Medical Group, The Private Phototherapy Clinic Ltd, and Massachusetts General Hospital

Request a Sample with TOC in a PDF format :https://www.marketresearchhub.com/enquiry.php?type=S&repid=1391926 

About Market Research Hub

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Research Assistance

For Enquiries, Call :

+1-800-998-4852US Toll Free

Email : sales@marketresearchhub.com

Back To Top